Literature DB >> 24960036

Therapeutic effects of laparoscopic splenectomy and esophagogastric devascularization on liver cirrhosis and portal hypertension in 204 cases.

Zhe Cheng1, Jian-wei Li, Jian Chen, Yu-dong Fan, Peng Guo, Shu-guo Zheng.   

Abstract

OBJECTIVE: To investigate the effects and technical points of laparoscopic splenectomy and esophagogastric devascularization (LS+ED) for portal hypertension (PH) due to liver cirrhosis. SUBJECTS AND METHODS: In total, 204 PH patients who underwent LS+ED from January 2008 to April 2013 in the Southwest Hospital of the Third Military Medical University were enrolled in this study. We retrospectively analyzed the clinical data and the key technical points and compared the results with other researchers.
RESULTS: LS+ED was successfully carried out on 188 patients. The mean duration of surgery was 232±59 minutes, the mean intraoperative blood loss was 189±137 mL, the rate of blood transfusion was 19.6% (40/204), and no deaths occurred during surgery. The mean postoperative interval to passing of flatus was 3.5±0.9 days, and the mean postoperative hospital stay was 8.7±2.2 days. Operative complications occurred in 100 patients, of whom 78 had portal vein system thrombosis (PVST). During a postoperative follow-up period of 2-65 months, 15 cases were lost to follow-up, esophagogastric variceal bleeding re-occurred in 7 patients, encephalopathy occurred in 2 patients, and secondary liver cancer occurred in 3 patients. Five patients died during this period.
CONCLUSIONS: The technical points of LS+ED include a combined surgical approach, a reasonable surgical procedure, and an appropriate laparoscopic operating plane. LS+ED is a safe and effective treatment for minimal trauma and rapid recovery. PVST is a common and potentially life-threatening complication after LS+ED, and anticoagulation therapy should be given early.

Entities:  

Mesh:

Year:  2014        PMID: 24960036     DOI: 10.1089/lap.2014.0036

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  11 in total

1.  Clinical effects of cluster technology optimization and innovations on laparoscopic splenectomy and azygoportal disconnection: a single-center retrospective study with 500 consecutive cases.

Authors:  Long-Fei Wu; Dou-Sheng Bai; Rong-Hua Gong; Sheng-Jie Jin; Chi Zhang; Bao-Huan Zhou; Jian-Jun Qian; Guo-Qing Jiang
Journal:  Surg Endosc       Date:  2022-03-07       Impact factor: 3.453

2.  Robotic-assisted versus laparoscopic approach of Bai-Jiang-style vagus nerve-preserving splenectomy and azygoportal disconnection.

Authors:  Dou-Sheng Bai; Sheng-Jie Jin; Xiao-Xing Xiang; Jian-Jun Qian; Chi Zhang; Bao-Huan Zhou; Guo-Qing Jiang
Journal:  Updates Surg       Date:  2022-01-07

3.  Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients.

Authors:  Xingshun Qi; Guohong Han; Chun Ye; Yongguo Zhang; Junna Dai; Ying Peng; Han Deng; Jing Li; Feifei Hou; Zheng Ning; Jiancheng Zhao; Xintong Zhang; Ran Wang; Xiaozhong Guo
Journal:  Med Sci Monit       Date:  2016-07-19

4.  Retrospective Study to Compare Selective Decongestive Devascularization and Gastrosplenic Shunt versus Splenectomy with Pericardial Devascularization for the Treatment of Patients with Esophagogastric Varices Due to Cirrhotic Portal Hypertension.

Authors:  Haili Bao; Qikuan He; Ninggao Dai; Ruifan Ye; Qiyu Zhang
Journal:  Med Sci Monit       Date:  2017-06-08

5.  Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China.

Authors:  Ruoyang Shao; Zhiwei Li; Jitao Wang; Ruizhao Qi; Qingbo Liu; Weijie Zhang; Xiaorong Mao; Xiaojing Song; Lei Li; Yanna Liu; Xin Zhao; Chuan Liu; Xun Li; Changzeng Zuo; Weidong Wang; Xiaolong Qi
Journal:  BMJ Open       Date:  2020-06-23       Impact factor: 2.692

6.  Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: A single-center experience.

Authors:  Shunzhen Zheng; Ping Sun; Xihan Liu; Guangbing Li; Wei Gong; Jun Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension.

Authors:  Jie Lin; Qingbo Liu; Zhiqiang Liang; Wei He; Jianping Chen; Jing Ma; Chichang Gu; Weidong Wang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-12-10       Impact factor: 1.195

8.  Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt.

Authors:  Yingying Li; Zuojin Liu; Chang'an Liu
Journal:  BMC Gastroenterol       Date:  2021-02-11       Impact factor: 3.067

Review 9.  Laparoscopic Splenectomy and Azygoportal Disconnection: a Systematic Review.

Authors:  Guo-Qing Jiang; Dou-Sheng Bai; Ping Chen; Jian-Jun Qian; Sheng-Jie Jin
Journal:  JSLS       Date:  2015 Oct-Dec       Impact factor: 2.172

10.  Association Between Changes in Splanchnic Hemodynamics and Risk Factors of Portal Venous System Thrombosis After Splenectomy with Periesophagogastric Devascularization.

Authors:  Long Huang; Qingsheng Yu; Jiajia Wang
Journal:  Med Sci Monit       Date:  2018-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.